Spontaneous changes of heart rate, blood pressure, and ischemia-type ST-segment depressions in patients with hypertension without significant coronary artery disease: beneficial effects of beta-blockade

Journal of Cardiovascular Pharmacology
M ChristM Wehling

Abstract

In hypertensives, a reduced coronary flow reserve is observed and may contribute to angina pectoris and silent (painless) myocardial ischemia, which frequently occur in these patients even in the absence of coronary artery disease (CAD). To assess the frequency of ischemia-type ST-segment depressions in these patients and the influence of heart rate (HR) and blood pressure (BP) as major determinants of myocardial oxygen demand and to test the effects of beta-blocker therapy (10-20 mg betaxolol/day for 4 weeks) on these variables, simultaneous 24-h Holter and 24-h ambulatory BP monitoring was performed in 19 patients with hypertension (age, 43-71 years; nine women, 10 men) without CAD (stenosis < 50% in angiography). Before treatment, 25 periods of significant ST-segment depressions with a total duration of 470 min were observed in nine patients. ST-segment depressions were significantly correlated with preceding increases in HR and the rate-pressure product. The majority (79%) of episodes with ST-segment depression were clinically painless. In this open study, beta-blockade significantly decreased the number of episodes with ST-segment depressions to six in four of 15 patients and the total duration to 38 min (p < 0.05). The da...Continue Reading

References

Oct 22, 1979·The American Journal of Cardiology·B E Strauer
Nov 1, 1977·Circulation·N J Fortuin, J L Weiss
May 11, 1975·The American Journal of Cardiology·M M IbrahimR W Gifford
Oct 1, 1992·The New England Journal of Medicine·E D FrohlichB Massie
Nov 1, 1991·Hypertension·E D Frohlich
Nov 1, 1991·Hypertension·W S Peart
Jun 1, 1989·Journal of the American College of Cardiology·A LangerP W Armstrong
May 8, 1986·The New England Journal of Medicine·S O GottliebG Gerstenblith
Dec 12, 1987·Lancet·J van HartenD D Breimer
Sep 24, 1987·The New England Journal of Medicine·J M McLenachanH J Dargie
Nov 17, 1988·The New England Journal of Medicine·J E BrushS E Epstein
Nov 1, 1987·The American Journal of Cardiology·D TzivoniS Stern
May 1, 1970·Annals of Internal Medicine·D RoitmanL T Sheffield
Jul 1, 1984·The American Journal of Medicine·F H MesserliE D Frohlich
Jan 1, 1983·Physiological Reviews·E O Feigl
Dec 1, 1984·The American Journal of Cardiology·J E DeanfieldA P Selwyn
Mar 1, 1982·American Journal of Epidemiology·E M WroblewskiA A Bove
Dec 1, 1984·The American Journal of Cardiology·J E DeanfieldA P Selwyn
Nov 1, 1983·British Heart Journal·A A QuyyumiK Fox
May 1, 1984·Hypertension·M HartfordG Berglund

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.